Businesses that produce bioscience products—gene tests and therapies, pharmaceuticals, vaccines, and medical devices—are regularly confronted with ethical issues concerning these technologies. Conflicts exist between those who support advancements in bioscience and those who fear the consequences of unfettered scientific license. As the debate surrounding bioscience grows, it will be increasingly important for business managers to consider the larger consequences of their work. This groundbreaking book follows industry research, development, and marketing of medical and bioscience products across a variety of fields, including biotechnology, pharmaceuticals, and bio-agriculture. Compelling and current case studies highlight the ethical decisions business managers frequently face. With the increasing visibility and public expectation placed on businesses in this sector, managers need to understand the ethical and social issues. This book addresses that need and provides a framework for incorporating ethical analysis in business decision making.

This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.

Ethics.

This book introduces bioengineers and students who must generate and/or report scientific data to the ethical challenges they will face in preserving the integrity of their data. It provides the perspective of reaching ethical decisions via pathways that treat data as clients, to whom bioengineering scientists owe a responsibility that is an existential component of their professional identity. The initial chapters lay a historical, biological and philosophical foundation for ethics as a human activity, and data as a foundation of science. The middle chapters explore ethical challenges in lay, engineering, medical and bioengineering scientist settings. These chapters focus on micro-ethics, individual behavior, and cases that showcase the consequences of violating data integrity. Macro-ethics, policy, is dealt with in the Enrichment sections at the end of the chapters, with essay problems and subjects for debates (in a classroom setting). The book can be used for individual study, using links in the Enrichment sections to access cases and media presentations, like PBS’ "Ethics in America". The final chapters explore the impact of bioengineering science ethics on patients, via medical product development, its regulation by the FDA, and the contribution of data integrity violation to product failure. The book was developed for advanced undergraduate and graduate students in bioengineering. It also contains much needed material that researchers and academics would find valuable (e.g., FDA survey, and lab animal research justification). Introduces an approach to ethical decision making based on treating data as clients Compares the ethics of three professions; engineering, medicine and bioengineering Provides five moral theories to choose from for evaluating ethical decisions, and includes a procedure for applying them to moral analysis, and application of the procedure to example cases. Examines core concepts, like autonomy, confidentiality, conflict of interest and justice Explains the process of developing a medical product under FDA regulation Explores the role of lawyers and the judiciary in product development, including intellectual property protection Examines a range of ethical cases, from the historical Tuskegee autonomy case to the modern CRISPR-Cas9 patent case. Howard Winet, PhD is an Adjunct Professor recall, Orthopaedic Surgery and Bioengineering at University of California, Los Angeles.

Public service professionals government officials, those in the legal system, first responders, and investigators confront ethical issues every day. In an environment where each decision can mean the difference between life and death or freedom and imprisonment, deciding on an ethical course of action can pose challenges to even the most season

Designer babies: choosing our children -- Haven't I seen you before? -- Exchange parts for everybody -- How to improve yourself -- Who wants to live forever? -- Big brother is watching your genome -- Something on your mind? -- Playing God -- Trust me, I'm a scientist!

Economics and moral philosophy have in recent years been considered to be distinct and separate fields. However, behavioural economics has started to reconcile various aspects of morality and economics, which has offered new conceptual opportunities to advance economics ethics and business ethics. This book aims to advance economic ethics and business ethics by combining normative principles and empirical evidence grounded on the key motivational forces in economic decision making. It has three core objectives: to assess order ethics as a theory of both economic ethics and business ethics, using behavioural economics methods and evidence; to identify cardinal virtues for modern business ethics; to to set up valuable guidelines for the implementation of economic ethics and business ethics.